The Model for End-stage Liver Disease Comes of Age

descriptionPublicationkeyboard_double_arrow_right Article 01 May 2007 English Publisher:Elsevier BVJournal:Clinics in Liver Disease, volume 11, pages 249-263 (issn: 1089-3261,

Copyright policy )

Authors: Richard B, Freeman;

doi: 10.1016/j.cld.2007.04.005

pmid: 17606205

The Model for End-stage Liver Disease Comes of Age

- Summary
- Subjects
- Metrics

Abstract

The care of patients who have chronic liver disease has evolved considerably since the Model for End-stage Liver Disease (MELD) was first described 6 years ago. This article traces the progress in liver allocation and clinical liver disease research that includes the MELD score and highlights the management of areas in which MELD and the principles underlying MELD enhance the clinician's ability to understand better the patient who has chronic liver disease.

Related Organizations

Tufts Medical Center
United States

Keywords

Tissue and Organ Procurement, Chronic Disease, Humans, Models, Biological, Severity of Illness Index, Liver Failure, Liver Transplantation

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	29
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Top 10%
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Top 10%